Cell And Gene Therapy Clinical Trials Market 2033: Oncology Drives the Surge
Global Cell and Gene Therapy Clinical Trials Market Overview The global cell and gene therapy (CGT) clinical trials market was valued at USD 10.75 billion in 2024 and is projected to reach USD 39.41 billion by 2033, growing at a CAGR of 15.58% from 2025 to 2033. The market growth is primarily driven by increasing R&D investments, rising patient demand for innovative therapies, expanding applications of cell and gene therapies in cancer treatment, and a supportive regulatory landscape across key regions. The acceleration of innovation in genetic medicine, coupled with growing regulatory support for advanced therapies, has significantly boosted the CGT clinical trials market. Cutting-edge technologies such as CRISPR genome editing and advances in viral and non-viral vector delivery systems have enabled researchers to design highly precise therapeutic candidates for rare genetic disorders, oncology, and autoimmune diseases. Regulatory agencies, including the U.S. FDA and the Europ...